🇺🇸 FDA
Patent

US 7253147

Modified serum albumin with reduced affinity for nickel and copper

granted A61KA61K2800/86A61K47/42

Quick answer

US patent 7253147 (Modified serum albumin with reduced affinity for nickel and copper) held by New Century Pharmaceuticals, Inc. expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
New Century Pharmaceuticals, Inc.
Grant date
Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2800/86, A61K47/42, A61K8/345, A61K8/64